🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II, open-label, multi-center, competitive enrollment and...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2011-09-06
Trial ID
NCT01326871
Treatments Being Tested
This study will evaluate the efficacy and safety of ALT-801 once-weekly ver...
Status
Completed
Location
Altimmune CTM
Start Date
2022-03-31
Trial ID
NCT05295875
This is a Phase Ib/II, open-label, multi-center, competitive enrollment and...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2010-02
Trial ID
NCT01029873
This is a single-center open-label phase I clinical trial of delivering hap...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2011-11
Trial ID
NCT01478074
Treatments Being Tested
This is a Phase Ib/II, open-label, multi-center and competitive enrollment ...
Status
Terminated
Location
University of Iowa Hospitals
Start Date
2012-08-14
Trial ID
NCT01670994
Treatments Being Tested
This is a Phase 1, open-labeled, non-randomized, multi-center, competitive ...
Status
Completed
Location
University of Colorado, Anschutz Cancer Pavillion
Start Date
2007-05
Trial ID
NCT00496860
Treatments Being Tested
This is a Phase 1, open-label, drug-drug interaction (DDI) study of pemvidu...
Status
Completed
Location
CMAX Clinical Research
Start Date
2021-09-15
Trial ID
NCT04972396
Treatments Being Tested
This is a Phase 1, randomized, double-blind, placebo-controlled, parallel g...
Status
Completed
Location
Altimmune CTM
Start Date
2022-02-01
Trial ID
NCT05134662
This is a Phase Ib/II, open-label, multi-center and competitive enrollment ...
Status
Terminated
Location
University of Alabama Comprehensive Cancer Center
Start Date
2012-03-30
Trial ID
NCT01625260
Treatments Being Tested
The purpose of the study is to assess the safety and tolerability of ALT-80...
Status
Completed
Location
Headlands Research Scottsdale
Start Date
2021-09-30
Trial ID
NCT05006885